Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets

Blood

Volumn 91, Issue 2, 1998, Pages 500-507

  Varon, David ^b   Jackson, Denise E ^b   Shenkman, Boris ^b   Dardik, Rima ^b   Tamarin, Llya ^b   Savion, Naphtali ^b   Newman, Peter J ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CD31 ANTIGEN; INTEGRIN; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; MOLECULAR INTERACTION; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0031982997     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.500     Document Type: Article

References (62)

1. Newman PJ: The biology of PECAM-1. J Clin Invest 99:3, 1997
2. Newman PJ, Berndt MC, Gorski J, White GC, Lyman S, Paddock C, Muller WA: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219, 1990
3. Newman PJ, Hillery CA, Albrecht R, Parise LV, Berndt MC, Mazurov AV, Dunlop LC, Zhang J, Rittenhouse SE: Activation-dependent changes in human platelet PECAM-1: Phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol 119:239, 1992
4. Zehnder JL, Hirai K, Shatsky M, McGregor JL, Levitt LJ, Leung LLK: The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J Biol Chem 267:5243, 1992
5. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 82:2649, 1993
6. Jackson DE, Ward CM, Wang R, Newman PJ: The protein-tyrosine phosphatase, SHP-2, binds PECAM-1 and forms a distinct signaling complex during platelet aggregation: Evidence for a mechanistic link between PECAM-1-and integrin-mediated signal transduction. Blood 88:438a, 1996 (abstr, suppl 1)
7. Bogen SA, Baldwin HS, Watkins SC, Albelda SM, Abbas AK: Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol 141:843, 1992
8. Johnson BA, Haines GK, Harlow LA, Koch AE: Adhesion molecule expression in human synovial tissue. Arthritis Rheum 36:137, 1993
9. Tang Q, Hendricks RL: Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into Herpes Simplex virus-infected mouse corneas. J Exp Med 184:1435, 1996
10. Ioffreda MD, Albelda SM, Elder DE, Radu A, Leventhal LC, Zweiman B, Murphy GF: TNFα induces E-selectin expression and PECAM-1 (CD31) redistribution in extracutaneous tissues. Endothelium 1:47, 1993
11. Romer LH, McLean NV, Van H-C: IFN-gamma and TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol 154:6582, 1995
12. Stewart RJ, Kashour TS, Marsden PA: Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 156:1221, 1996
13. Rival Y, Maschio AD, Rabiet M-J, Dejana E, Duperray A: Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cell by the combined action of TNF-α and IFN-gamma. J Immunol 157:1233, 1996
14. Zocchi MR, Ferrero E, Leone BE, Rovere P, Bianchi E, Toninelli E, Pardi R: CD31/PECAM-1-driyen chemokine-independent transmigration of human T lymphocytes. Eur J Immunol 26:759, 1996
15. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration leukocytes. J Exp Med 178:449, 1993
16. Vaporciyan AA, DeLisser HM, Yan H-C, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM: Involvement of platelet endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262:1580, 1993
17. Bogen S, Pak J, Garifallou M, Deng X, Muller WA: Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 179:1059, 1994
18. Wakelin MW, Sanz M-J, Dewar A, Albelda SM, Larkin SW, Boughton-Smith N, Nourshargh S: An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med 184:229, 1996
19. Murohara T, Delyani JA, Albelda SM, Lefer AM: Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 156:3550, 1996
20. Gumina RJ, Schultz JE, Yao Z, Kenny D, Warltier DC, Newman PJ, Gross GJ: Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 94:3327, 1996
21. Fawcett J, Buckley C, Holness CL, Bird IN, Spragg JH, Saunders J, Harris A, Simmons DL: Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol 128:1229, 1995
22. Sun Q-H, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ: Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 271:11090, 1996
23. Sun J, Williams J, Yan H-C, Amin KM, Albelda SM, DeLisser HM: Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem 271:18561, 1996
24. 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 130:451, 1995
25. Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, Simmons DL: Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 109:437, 1996
26. Prager E, Sunder-Plassmann R, Hansmann C, Koch C, Holter W, Knapp W, Stockinger H: Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J Exp Med 184:41, 1996
27. Tanaka Y, Albelda SM, Horgan KJ, Van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S: CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J Exp Med 176:245, 1992
28. + hemopoietic progenitor cells. J Immunol 153:4673, 1994
29. Piali L, Albelda SM, Baldwin HS, Hammel P, Gisler RH, Imhof BA: Murine platelet enbdothelial cell adhesion molecule (PECAM-1/ CD31) modulates β2 integrins on lymphokine-activated killer cells. Eur J Immunol 23:2464, 1993
30. Berman ME, Muller WA: Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 154:299, 1995
31. 2 integrin activation. J Immunol 156:1515, 1996
32. Mazurov AV, Vinogradov DV, Kabaeva NV, Antonova AN, Romanov YA, Vlasik TN, Antonov AS, Smirnov VN: A monoclonal antibody, VM64, reacts with a 130 kDa glycoprotein common to platelets and endothelial cells: Heterogeneity in antibody binding to human aortic endothelial cells. Thromb Haemost 66:494, 1991
33. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK: Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost 66:700, 1991
34. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE: Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88:907, 1996
35. Van H-C, Pilewski JM, Zhang Q, DeLisser HM, Romer L, Albelda SM: Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping. Cell Adhesion Commun 3:45, 1995
36. Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA: Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182:1337, 1995
37. Rosenfeld SI, Looney RJ, Leddy JP. Phipps DC, Abraham GN, Anderson CL: Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest 76:2317, 1985
38. Kouns WC, Wall CD, White MM, Fox CF, Jennings LK: A conformation-dependent epitope of human platelet glycoprotein IIIa. J Biol Chem 265:20594, 1990
39. McEver RP, Martin MN: A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 259:9799, 1984
40. Gospodarowicz D, Greenburg G, Foidart JM, Savion N: The production and localization of laminin in cultured vascular and corneal endothelial cells. J Cell Physiol 107:171, 1981
41. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N: A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Throm Res 85:283, 1997
42. Ohto H, Maeda H, Shibata Y, Chen R-F, Qzaki Y, Higashihara M, Takeuchi A, Tohyama H: A novel leukocyte differentiation antigen: Two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood 66:873, 1985
43. Jackson DE, Ward CM, Wang R, Newman PJ: The protein-tyrosine phosphatase SHP-2 binds PECAM-1 and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1 and integrin-mediated cellular signaling. J Biol Chem 272:6986, 1997
44. Stockinger H, Gadd SJ, Eher R, Majdic O, Schreiber W, Kasinrerk W, Strass B, Schnabl E, Knapp W: Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 145:3889, 1990
45. Chen W, Khapp W, Majdic O, Stockinger H, Bohmig :GA, Zlabinger GJ: Co-ligation of CD31 and FcgammaRII induces cytokine production in human monocytes. J Immunol 152:3991, 1994
46. Poggi A, Panzeri MC, Moretta L, Zocchi MR: CD31-triggered rearrangement of the actin cytoskeleton in human natural killer cells. Eur J Immunol 26:817, 1996
47. Levine BL, Ueda Y, Faith A, June CH: Signal transduction properties of the T cell activation monoclonal antibody panel: Ubiquitous increase in cellular substrate tyrosine phosphorylation in the absence of detectable calcium mobilization. Tissue Antigens 48:319, 1996
48. El Marsafy S, Carosella ED, Agrawal SG, Gluckman E, Mansur I-G, Elhabazi A, Bensussan A: Functional role of PECAM-1/CD31 molecule expressed on human cord blood progenitors. Leukemia 10:1340, 1996
49. Takada Y, Hemler ME: The primary structure of the VLA-2/ collagen receptor alpha 2 subunit (platelet GPIa): Homology to other integrals and the presence of a possible collagen-binding domain. J Cell Biol 109:397, 1989
50. Kelton JG, Sheridan D, Santos A, Smith J, Sleeves K. Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: Laboratory studies. Blood 72:925, 1988
51. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81, 1993
52. Kumpel BM, van de Winkel JGJ, Westerdaal NAC, Hadley AG. Dugoujon JM, Blancher A: Antigen topography is critical for interaction of IgG2 anti-red-cell antibodies with Fcgamma receptors. Br J Haematol 94:175, 1996
53. Horsewood P, Hayward CPM, Warkentin TE, Kelton JG: Investigation of the mechanism of monoclonal antibody-induced platelet activation. Blood 78:1019, 1991
54. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH: Response of human platelets to activating monoclonal antibodies: Importance of FcgammaRII (CD32) phenotype and level of expression. Blood 80: 2261, 1992
55. Anderson CL, Chacko GW, Osborne JM, Brandt JT: The Fc receptor for immunoglobulin G (FcgammaRII) on human platelets. Semin Thromb Hemost 21:1, 1995
56. Jackson DE, Loo RO, Holyst MT, Newman PJ: Identification and characterization of functional cation coordination sites in platelet endothelial cell adhesion molecule-1 (PECAM-1). Biochemistry 36: 9395, 1997
57. Zehnder JL, Shatsky M, Leung LLK, Butcher EC, McGregor JL, Levitt LJ: Involvement of CD31 in lymphocyte-mediated immune responses: Importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. Blood 85:1282, 1995
58. Chen Y, Schlegel PG, Tran N, Thompson D, Zehnder JL, Chao NJ: Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease. Blood 89:1452, 1997
59. Osawa M, Masuda M, Harada N, Lopes RB, Fujiwara K: Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in mechanically stimulated vascular endothelial cells. Eur J Cell Biol 72:229, 1997
60. Sagawa K, Swaim W, Zhang J, Unsworth E, Siraganian RP: Aggregation of the hign affinity IgE receptor results in the tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31). J Biol Chem 272:13412, 1997
61. Lu TT, Yah LG, Madri JA: Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion moleculel 1. Proc Natl Acad Sci USA 93:11808, 1996
62. Du XP, Plow EF, Frelinger AL, O'Toole TE, Loftus JC, Ginsberg MH: Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell 65:409, 1991